Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurol Clin. 2009 Nov;27(4):1003-13. doi: 10.1016/j.ncl.2009.06.001.

Identification of pharmacoresistant epilepsy.

Author information

  • 1Department of Biology, Northern Illinois University, DeKalb, IL 60115, USA. atberg@niu.edu

Abstract

There is no single definition of pharmacoresistant (intractable, refractory) epilepsy. Prospective identification of pharmacoresistance is complicated by the variability of its appearance across different types of epilepsy and the variability of seizure control within a given patient over time. Failure of informative trials of two appropriate antiepileptic drugs has been recommended as a threshold that should trigger referral for evaluation at a comprehensive epilepsy center. Maximizing seizure control is imperative for reducing the risks and consequences of epilepsy, including the cognitive and psychiatric comorbidities and even sudden death.

PMID:
19853220
[PubMed - indexed for MEDLINE]
PMCID:
PMC2827183
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk